Figure 1: Model schematic showing impact of test results for the novel prognostic test
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Supplemental Digital Content 3: Outcomes Data
Similar to relative risk data, clinical outcomes data were available only for certain time points in gestation. These data were also curve fitted to generate estimated week-by-week rates in the model population The assumption was made that all costs in the model would follow the same distribution from the average by gestational age as that reported for acute costs.
Supplemental Digital Content 5: Univariate Sensitivity Analysis
The cost of vaginal progesterone was varied within the range provided in Cahill (2010) with dollar values inflated to 2015 ($240-$375, with a base of $307).
The following inputs were varied ±20% because the data source did not provide confidence intervals for these data points. The average mortality for births between 23 weeks and full term was calculated as 11%.
A distribution factor for each gestational age was calculated as the base mortality rate at that gestational age (e.g., 57% at 23 weeks) divided by the average mortality (11%).
The average was then varied ±20% in the univariate sensitivity analysis and multiplied by the distribution factor to determine the corresponding week-by-week mortality rate as shown in the table below.
This analysis assumes that the varied outcome (e.g., mortality, acute cost, vision impairment, etc., will always follow the same distribution as it does in the base case scenario, but allows the week-by-week inputs to vary by the same amount for each outcome rather than independently. 
